Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00443300 · ClinicalTrials.gov registry record
Effectiveness of Protected Environment Rooms for AML and MDS
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Terminated
- Registry status
- 3
- Enrollment target
NCT00443300: Clinical Trial study, sponsored by M.D. Anderson Cancer Center.
NCT00443300 is a clinical trial that was terminated before completion, run by M.D. Anderson Cancer Center. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00443300 was terminated before completion, sponsored by M.D. Anderson Cancer Center.
- TERMINATED
- Registry status
- 3 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to learn if the "protected environment" (PE) can help to prevent infections in patients aged 60 and above who are receiving what is considered low-intensity treatment for newly-diagnosed AML or high-risk MDS.
Primary Outcome
Success is defined as number of participants with no death, pneumonia, or sepsis within 6 weeks of randomization compared to total number of participants to evaluate effect of the protected environment (PE) by (adaptively) randomly assigning patients age \>/= 60 given targeted therapies between treatment inside or outside the PE.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2007-01 |
| Est. Completion | 2008-01 |
Why NCT00443300 stopped before completion
NCT00443300 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 3 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00443300 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00443300 about?
NCT00443300 is a clinical study titled "Effectiveness of Protected Environment Rooms for AML and MDS". The goal of this clinical research study is to learn if the "protected environment" (PE) can help to prevent infections in patients aged 60 and above who are receiving what is considered low-intensity treatment for newly-diagnosed AML or high-risk MDS.
What is the current status of trial NCT00443300?
This trial is currently terminated. The enrollment target is 3 participants. The study started on 2007-01. Estimated completion is 2008-01.
Who is sponsoring clinical trial NCT00443300?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia